Minimally Invasive Surgery Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Minimally Invasive Surgery Market

Minimally Invasive Surgery Market Size by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, electrosurgery, endoscopy)), Application (CVD, thoracic, neuro, ENT, OB/GYN, orthopedic), End-user, and Surgery volume - Global Forecast to 2029

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 1250 Mar, 2024, by marketsandmarkets.com

The size of global minimally invasive surgery market in terms of revenue was estimated to be worth $79.3 billion in 2024 and is poised to reach $173.9 billion by 2029, growing at a CAGR of 17.0% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

An increase in chronic disorders and the aging population, increasing research & funding initiatives from organizations, and worldwide advancement in surgical procedures are a few drivers that collectively contribute to the growth of the minimally invasive surgery market, and as healthcare technologies continue to evolve, the demand for minimally invasive surgical procedure is expected to rise further in the upcoming years. However, challenges for high cost, regulatory issues can limits the market growth.

Attractive Opportunities in the Minimally Invasive Surgery Market

Minimally Invasive Surgery Market

To know about the assumptions considered for the study, Request for Free Sample Report

Minimally Invasive Surgery Market

Minimally Invasive Surgery Market: Market Dynamics

Driver: Increase adoption of MIS over open surgeries

Laparoscopic procedures are less invasive and save costs in terms of pre- and post-operation care and the length of stay in hospitals. These surgeries result in less blood loss, fewer postoperative complications, and a shorter recovery time for patients. In addition, minimally invasive surgeries are increasingly being covered by health insurance providers in select countries. Physicians prefer minimally invasive surgeries over traditional open surgeries as they consider it to be a cost-saving opportunity for hospitals.

Restraint: High cost of Robotic systems

Robot-assisted surgeries are much more expensive than minimally invasive surgeries. This often results in deferred or altogether avoided treatments. The high cost of robotic surgery is further increased by the fact that the annual maintenance cost of robots is around USD 125,000. Hospital budget cuts were similar throughout European countries, and more cuts are anticipated in the upcoming years. Budget cuts have made cost-containment measures necessary in many areas of hospital operations.

Opportunity: Emerging markets- growth opportunities

Emerging markets are evolving into growth areas for the minimally invasive surgery. A myriad of factors contribute to the growth opportunities within these markets, attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure, escalating disposable incomes, and a burgeoning aging demographic. Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn top players in the minimally invasive surgery market to focus on emerging countries.

Challenge: High degree of market consolidaton

The minimally invasive surgery market is highly consolidated. Only key companies are able to afford high capital invaestments as well as the high cost of research & development and manufacturing. It will prevent new entrant to enter the minimally invasive surgery market. Top player salso enjoys the high degree of brand loyalty. Whereas new entrant have to compete with existing key players to offer and set themselves by developing innovative product offerings.

Minimally Invasive Surgery Industry Ecosystem

Major companies in this market include well-established and financially stable suppliers of minimally invasive surgery. Prominent companies in this market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker corporation (US), NuVasive (US), Abbott Laboratories (US), Zimmer Biomet holdings (Warsaw), Boston Scientific Corporation (US), GE Healthcare (US) among several others.

Minimally Invasive Surgery Market Ecosystem

Surgical devices segment to register largest market share of minimally invasive surgery industry in the year 2023.

Based on the product, the minimally invasive surgery market is segmented into Surgical Devices, Imaging & Visualization Systems, Endoscopy Devices, Electrosurgical Devices, and Medical Robotics. Surgical Devices segment to register largest market share in the forecast period of 2023-2029. The surgical devices further divided into Handheld instruments, laparoscopy devices, guiding devices and inflation system. Key drivers fostering the expansion of minimally invasive surgery (MIS) via surgical devices encompass ongoing technological advancements, which continuously elevate the precision, adaptability, and safety of these instruments. Furthermore, the market's growth is further bolstered by the introduction of advance surgical technologies by key industry players.

Nerological Surgery segment is the highest market rate application segment of minimally invasive surgery industry in the forecasted year 2024-2029.

The Neurological surgery application segment register highest market rate in the forecasted year 2024-2029 . Key factors propelling the adoption of minimally invasive surgery (MIS) in neurological procedures include advancements in technology, particularly in imaging modalities and surgical instrumentation, which enable more precise and minimally invasive interventions. Additionally, the imperative to minimize patient morbidity, lower post-operative complications, and accelerate recovery periods serves as a significant impetus for the adoption of MIS in neurological surgery. Furthermore, evolving healthcare paradigms prioritizing value-based care and patient-centric outcomes further propel the integration of MIS in neurological surgery.

Asia-Pacific is expected to be the highest CAGR of minimally invasive surgery industry during the forecast period.

The minimally invasive surgery market is divided into key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America held the largest market share in the global minimally invasive surgery market. However, the Asia Pacific region is anticipated to exhibit the highest CAGR during the forecast period. This growth is primarily attributed to the a rise in healthcare budgets, demographic shift with a rapidly aging population,and investing in healthcare infrastructure. Patients increasingly seek minimally invasive alternatives to traditional surgery due to the perceived benefits, such as shorter hospital stays, reduced pain, and quicker recovery. As patient awareness and demand for MIS options rise, healthcare providers are more likely to offer and promote these procedures. This includes advancements in surgical techniques and the adoption of advanced minimally invasive surgery. Additionally, the market in the Asia Pacific region is set to receive a boost from the growing number of local manufacturers offering minimally invasive surgery products.

Minimally Invasive Surgery Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2023, prominent players in the market are Medtronic plc (Ireland), Johnson & Johnson Medtech (US), Stryker corporation (US), NuVasive (US), GE Healthcare (US), Zimmer Biomet holdings (Warsaw), Becton, Dickinson & Company. (US), Boston Scientific Corporation (US), Abbott Laboratories (US) among several others.

Scope of the Minimally Invasive Surgery Industry:

Report Metric

Details

Market Revenue in 2024

$79.3 billion

Projected Revenue by 2029

$173.9 billion

Revenue Rate

Poised to Grow at a CAGR of 17.0%

Market Driver

Increase adoption of MIS over open surgeries

Market Opportunity

Emerging markets- growth opportunities

This report has segmented the Minimally invasive surgery market to forecast revenue and analyze trends in each of the following submarkets:

By Product
  • SURGICAL DEVICES
    • HANDHELD INSTRUMENTS
      • Tubular Retractor
      • Dilator
      • Suturing Instruments
        • Probes
        • Laser fiber devices
    • GUIDING DEVICES
      • Guiding catheters
      • Guidewires
    • INFLATION SYSTEMS
      • Balloon Catheters
      • Balloon inflation system
    • LAPAROSCOPY DEVICES
      • Laparoscope
      • Trocar and Cannula
      • RASP (Robotic- Assisted Simple Prostatectomy)
      • Graspers and Dissectors
  • IMAGING & VISUALIZATION SYSTEMS
    • Ultrasound
    • CT imaging
    • MRI imaging
    • X-Ray imaging
    • Visualization systems
  • ELECTROSURGICAL DEVICES
    • Electrosurgical generators & accessories
    • Electrocautery devices
  • ENDOSCOPY DEVICES
    • Rigid endoscopes
    • Flexible endoscopes
    • Diagnostic endoscopes
  • MEDICAL ROBOTICS
    • Robotic Systems
    • Robotic Instruments
    • Robotic softwares & Services
By Application
  • Cardio-Thoracic Surgery
  • Vascular Surgery
  • Neurological Surgery
  • Ent & Respiratory Surgery
  • Cosmetic Surgery
  • Gastrointestinal & Abdominal Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Orthopedic Surgery
  • Oncology Surgery
  • Dental Surgery
  • Others
By End User
  • Hospitals, Clinics & Ablation centers
  • Ambulatory Surgical Centers
  • Orthopedic, Emergency & Trauma Centers
  • Others
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
  • MEA

Recent Market Developments of Minimally Invasive Surgery Industry:

  • In 2023, Medtronic receives CE Mark approval for Affera Mapping and Ablation System to treat atrial arrhythmias.
  • In 2023, J&J MONARCH Platform is the first minimally invasive, robotic-assisted technology approved for bronchoscopy in China with significant burden of lung cancer.
  • In 2023, Stryker’s Q Guidance System for cranial applications received US FDA clearance to support cranial surgeries.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 41)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 MARKET STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
           1.5.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 46)
    2.1 RESEARCH DATA 
    2.2 RESEARCH DESIGN 
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY RESEARCH
                    2.2.2.1 Primary sources
                    2.2.2.2 Key industry insights
                    2.2.2.3 Breakdown of primaries
                                FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
                    2.3.1.2 Approach 2: Customer-based market estimation
                                FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
                    2.3.1.3 Approach 3: Top-down approach
                    2.3.1.4 Approach 4: Primary interviews
                                FIGURE 6 TOP-DOWN APPROACH
    2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH LIMITATIONS 
    2.6 STUDY ASSUMPTIONS 
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT ANALYSIS
    2.8 GROWTH RATE ASSUMPTIONS 
    2.9 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 62)
    FIGURE 8 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET
 
4 PREMIUM INSIGHTS (Page No. - 66)
    4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW 
          FIGURE 12 INCREASING ADOPTION OF MIS OVER OPEN SURGERIES TO DRIVE MARKET DURING FORECAST PERIOD
    4.2 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 
          FIGURE 13 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.3 MINIMALLY INVASIVE SURGERY MARKET, BY REGION AND END USER, 2023 (USD MILLION) 
          FIGURE 14 HOSPITALS, CLINICS, AND ABLATION CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.4 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET 
          FIGURE 15 FRANCE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 70)
    5.1 MARKET DYNAMICS 
          FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.1.1 DRIVERS
                    5.1.1.1 Increasing number of hospitals and surgeries
                    5.1.1.2 Increasing adoption of MIS over open surgeries
                    5.1.1.3 Advantages of robot-assisted surgery & training in rehabilitation therapy
                    5.1.1.4 Technological advancements
                                TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTS
           5.1.2 RESTRAINTS
                    5.1.2.1 Changing regulatory landscape in medical devices
                    5.1.2.2 High cost of robotic systems
           5.1.3 OPPORTUNITIES
                    5.1.3.1 Emerging markets
                    5.1.3.2 Increasing adoption of advanced robotics in ASCs
           5.1.4 CHALLENGES
                    5.1.4.1 High degree of market consolidation
    5.2 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.2.1 THREAT OF NEW ENTRANTS
           5.2.2 THREAT OF SUBSTITUTES
           5.2.3 BARGAINING POWER OF SUPPLIERS
           5.2.4 BARGAINING POWER OF BUYERS
           5.2.5 DEGREE OF COMPETITION
    5.3 TARIFF AND REGULATORY LANDSCAPE 
           5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.4 KEY REGULATORY GUIDELINES 
           5.4.1 US
                    TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.4.2 EUROPE
           5.4.3 JAPAN
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM
          FIGURE 18 MINIMALLY INVASIVE SURGERY MARKET: KEY PLAYERS
    5.6 TECHNOLOGY ANALYSIS 
           5.6.1 KEY TECHNOLOGIES
                    5.6.1.1 Laparoscopy
                    5.6.1.2 Ablation
                    5.6.1.3 Electrosurgery
                    5.6.1.4 Powered surgical products
           5.6.2 COMPLIMENTARY TECHNOLOGIES
                    5.6.2.1 Robotic surgery
                    5.6.2.2 Digital solutions (AI, IoT)
                    5.6.2.3 Medical/Surgical imaging
           5.6.3 ADJACENT TECHNOLOGIES
                    5.6.3.1 Endoscopes
                    5.6.3.2 Surgical implants
    5.7 VALUE CHAIN ANALYSIS 
           5.7.1 RESEARCH & DEVELOPMENT
           5.7.2 PROCUREMENT & PRODUCT DEVELOPMENT
           5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
                    FIGURE 19 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS
    5.8 SUPPLY CHAIN ANALYSIS 
           5.8.1 PROMINENT COMPANIES
           5.8.2 SMALL & MEDIUM-SIZED COMPANIES
           5.8.3 END USERS
                    FIGURE 20 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS
    5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
           5.9.2 KEY BUYING CRITERIA
    5.10 REIMBURSEMENT SCENARIO 
           TABLE 11 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
    5.11 PRICING ANALYSIS 
           FIGURE 21 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE PRODUCTS, BY PRODUCT (FY 2021-2023)
           FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION
    5.12 PATENT ANALYSIS 
           FIGURE 23 PATENT DETAILS FOR MINIMALLY INVASIVE SURGERY DEVICES (JANUARY 2013–DECEMBER 2023)
    5.13 TRADE ANALYSIS 
           TABLE 12 IMPORT DATA FOR MIS MARKET (HS CODE 9021), BY COUNTRY, 2018–2022 (USD THOUSAND)
           TABLE 13 EXPORT DATA FOR MIS MARKET (HS CODE 3822), BY COUNTRY, 2018–2022 (USD THOUSAND)
    5.14 CASE STUDIES 
           TABLE 14 CASE STUDY 1: ROLE OF MINIMALLY INVASIVE ROBOT-ASSISTED SURGERY IN UROLOGY
           TABLE 15 CASE STUDY 2: PIONEERING ROBOT-ASSISTED LATERAL LUMBAR INTERBODY FUSION (LLIF) WITH EXCELSIUSGPS
    5.15 KEY CONFERENCES AND EVENTS, 2023–2024 
           TABLE 16 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024
    5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 24 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
    5.17 MINIMALLY INVASIVE SURGERY MARKET: RECESSION IMPACT 
    5.18 UNMET CUSTOMER NEEDS IN MINIMALLY INVASIVE SURGERY MARKET 
    5.19 INVESTMENT SCENARIO 
           FIGURE 25 NUMBER OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022
           FIGURE 26 VALUE OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
 
6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT (Page No. - 99)
    6.1 INTRODUCTION 
          TABLE 17 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
    6.2 SURGICAL DEVICES 
          TABLE 18 SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 19 SURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.1 HANDHELD INSTRUMENTS
                    TABLE 20 HANDHELD INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    6.2.1.1 Tubular retractors
                               6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption
                    6.2.1.2 Dilators
                               6.2.1.2.1 Safety and efficient surgical site access to support adoption
                    6.2.1.3 Suturing instruments
                               6.2.1.3.1 Rising procedural volume and growing demand for MIS to drive market
                    6.2.1.4 Probes
                               6.2.1.4.1 Advancements in instrumentation and product launches to drive market
                    6.2.1.5 Laser fiber devices
                               6.2.1.5.1 Growing demand in urology, gastroenterology, and other specialties to support market growth
           6.2.2 GUIDING DEVICES
                    TABLE 21 GUIDING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    6.2.2.1 Guiding catheters
                               6.2.2.1.1 Focus on functional and design improvements to drive demand
                    6.2.2.2 Guidewires
                               6.2.2.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth
           6.2.3 INFLATION SYSTEMS
                    TABLE 22 INFLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    6.2.3.1 Balloon catheters
                               6.2.3.1.1 Technological advancements in balloon systems to support growth
                    6.2.3.2 Balloon inflation systems
                               6.2.3.2.1 Growing adoption of MIS in coronary and peripheral disease treatment to drive market
           6.2.4 LAPAROSCOPY DEVICES
                    TABLE 23 LAPAROSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    6.2.4.1 Laparoscopes
                               6.2.4.1.1 Lower risk of laparoscopic procedures to drive demand
                    6.2.4.2 Trocars & cannulas
                               6.2.4.2.1 Need to ensure accurate placement to support growth
                    6.2.4.3 Graspers & dissectors
                               6.2.4.3.1 Benefits such as increased safety and better reach to drive adoption
    6.3 IMAGING & VISUALIZATION SYSTEMS 
          TABLE 24 IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           TABLE 25 IMAGING & VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.1 ULTRASOUND SYSTEMS
                    6.3.1.1 Ultrasound to hold largest share of imaging & visualization systems market
                                TABLE 26 ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.2 CT SCANNERS
                    6.3.2.1 Shift toward image-guided interventions and rising disease prevalence to drive market
                                TABLE 27 CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.3 MRI SYSTEMS
                    6.3.3.1 Wide usage and technological advancements to support growth
                                TABLE 28 MRI SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.4 X-RAY SYSTEMS
                    6.3.4.1 Rising emphasis on digital X-ray systems to drive market
                                TABLE 29 X-RAY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.5 VISUALIZATION SYSTEMS
                    6.3.5.1 High levels of detail and better outcomes to drive demand
                                TABLE 30 VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.4 ELECTROSURGICAL DEVICES 
          TABLE 31 ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 32 ELECTROSURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.1 ELECTROCAUTERY DEVICES
                    6.4.1.1 Increasing plastic surgeries to drive market
                                TABLE 33 ELECTROCAUTERY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES
                    6.4.2.1 Growing use of disposables and reusable instruments to drive market
                                TABLE 34 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.5 ENDOSCOPY DEVICES 
          TABLE 35 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 36 ENDOSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.1 RIGID ENDOSCOPES
                    6.5.1.1 Rigid endoscopes to hold largest market share
                                TABLE 37 RIGID ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.2 FLEXIBLE ENDOSCOPES
                    6.5.2.1 Rising incidence of cancer to drive demand
                                TABLE 38 FLEXIBLE ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.3 DIAGNOSTIC ENDOSCOPES
                    6.5.3.1 Role of diagnostic endoscopes to expand due to versatility and sophistication
                                TABLE 39 DIAGNOSTIC ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.6 MEDICAL ROBOTICS 
          TABLE 40 MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 41 MEDICAL ROBOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.6.1 ROBOTIC SYSTEMS
                    6.6.1.1 Accuracy, efficiency, and ability to conduct highly complex procedures to support market growth
                                TABLE 42 ROB0TIC SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.6.2 ROBOTIC INSTRUMENTS
                    6.6.2.1 Rising demand for robotic surgical procedures to drive market
                                TABLE 43 ROB0TIC INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.6.3 ROBOTIC SOFTWARE & SERVICES
                    6.6.3.1 Need for basic training and expertise in robotic systems to drive market
                                TABLE 44 ROBOTIC SOFTWARE & SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION (Page No. - 122)
    7.1 INTRODUCTION 
          TABLE 45 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
    7.2 CARDIOTHORACIC SURGERY 
           7.2.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
                    TABLE 46 MINIMALLY INVASIVE SURGERY MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.3 VASCULAR SURGERY 
           7.3.1 BENEFITS SUCH AS PRECISE CUTS WITH LIMITED BLOOD LOSS IN VASCULAR SURGERY TO SUPPORT GROWTH
                    TABLE 47 MINIMALLY INVASIVE SURGERY MARKET FOR VASCULAR SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.4 NEUROLOGICAL SURGERY 
           7.4.1 INCREASING NUMBER OF PATIENTS SUFFERING FROM NEUROLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH
                    TABLE 48 MINIMALLY INVASIVE SURGERY MARKET FOR NEUROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.5 ENT & RESPIRATORY SURGERY 
           7.5.1 BENEFITS OF MIS IN HEAD AND NECK DISORDER TREATMENT TO DRIVE MARKET
                    TABLE 49 MINIMALLY INVASIVE SURGERY MARKET FOR ENT & RESPIRATORY SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.6 COSMETIC SURGERY 
           7.6.1 GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE MARKET
                    TABLE 50 MINIMALLY INVASIVE SURGERY MARKET FOR COSMETIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.7 GASTROINTESTINAL & ABDOMINAL SURGERY 
           7.7.1 RISING COLORECTAL CANCER PREVALENCE TO SUPPORT DEMAND
                    TABLE 51 MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL & ABDOMINAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.8 GYNECOLOGICAL SURGERY 
           7.8.1 GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED TO SUPPORT MARKET GROWTH
                    TABLE 52 MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.9 UROLOGICAL SURGERY 
           7.9.1 INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE ADOPTION OF MIS
                    TABLE 53 MINIMALLY INVASIVE SURGERY MARKET FOR UROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.10 ORTHOPEDIC SURGERY 
           7.10.1 RISING GERIATRIC POPULATION AND INCREASE IN ORTHOPEDIC DISORDERS TO DRIVE MARKET
                     TABLE 54 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.11 ONCOLOGICAL SURGERY 
           7.11.1 GROWING DEMAND FOR RADIOTHERAPY AND CHEMOTHERAPY TO AFFECT SEGMENT GROWTH
                     TABLE 55 MINIMALLY INVASIVE SURGERY MARKET FOR ONCOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.12 DENTAL SURGERY 
           7.12.1 EMPHASIS ON PREVENTIVE DENTAL CARE TO SUPPORT MARKET GROWTH
                     TABLE 56 MINIMALLY INVASIVE SURGERY MARKET FOR DENTAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
    7.13 OTHER SURGERIES 
           TABLE 57 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER SURGERIES, BY REGION, 2022–2029 (USD MILLION)
 
8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER (Page No. - 137)
    8.1 INTRODUCTION 
          TABLE 58 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
    8.2 HOSPITALS, CLINICS, AND ABLATION CENTERS 
           8.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE MARKET
                    TABLE 59 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, CLINICS AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)
    8.3 AMBULATORY SURGERY CENTERS 
           8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH
                    TABLE 60 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
    8.4 ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS 
           8.4.1 RISING USE OF ROBOTIC-ASSISTED SURGICAL SYSTEMS IN ORTHOPEDICS, EMERGENCY, AND TRAUMA CARE TO SUPPORT GROWTH
                    TABLE 61 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS, BY REGION, 2022–2029 (USD MILLION)
    8.5 OTHER END USERS 
          TABLE 62 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
 
9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION (Page No. - 144)
    9.1 INTRODUCTION 
          TABLE 63 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
                    TABLE 64 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 65 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 66 NORTH AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 67 NORTH AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 68 NORTH AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 69 NORTH AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 70 NORTH AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 71 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 72 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.2.2 US
                    9.2.2.1 US to dominate North American market
                                TABLE 73 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 74 US: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 75 US: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 76 US: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 77 US: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 78 US: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Rising cancer and IBD incidence to drive market
                                TABLE 79 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 80 CANADA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 81 CANADA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 82 CANADA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 83 CANADA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 84 CANADA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 85 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 86 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 87 EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 88 EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 89 EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 90 EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 91 EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 92 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 93 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Well-established healthcare system in Germany to boost usage of instruments
                                TABLE 94 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 95 GERMANY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 96 GERMANY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 97 GERMANY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 98 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 99 GERMANY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Rising number of hip & knee surgeries to drive market
                                TABLE 100 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 101 FRANCE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 102 FRANCE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 103 FRANCE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 104 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 105 FRANCE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.3.4 UK
                    9.3.4.1 High incidence of cancer in the UK to boost adoption of MIS instruments
                                TABLE 106 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 107 UK: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 108 UK: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 109 UK: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 110 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 111 UK: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Demand for MIS to positively affect market growth
                                TABLE 112 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 113 ITALY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 114 ITALY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 115 ITALY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 116 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 117 ITALY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Increasing incidence of CVD to boost adoption of MIS and drive market growth
                                TABLE 118 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 119 SPAIN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 120 SPAIN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 121 SPAIN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 122 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 123 SPAIN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 124 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 125 REST OF EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 126 REST OF EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 127 REST OF EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 128 REST OF EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 129 REST OF EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
                    TABLE 130 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 131 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 132 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 133 ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 134 ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 135 ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 136 ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 137 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 138 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Rising geriatric population in Japan to increase prevalence of chronic conditions and support market growth
                                TABLE 139 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 140 JAPAN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 141 JAPAN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 142 JAPAN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 143 JAPAN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 144 JAPAN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.4.3 CHINA
                    9.4.3.1 Rising disease prevalence and infrastructural improvements to support market growth
                                TABLE 145 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 146 CHINA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 147 CHINA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 148 CHINA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 149 CHINA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 150 CHINA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Healthcare infrastructure improvements and increasing geriatric population to drive market
                                TABLE 151 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 152 INDIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 153 INDIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 154 INDIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 155 INDIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 156 INDIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.4.5 AUSTRALIA
                    9.4.5.1 Uneven distribution of specialists to hinder market growth
                                TABLE 157 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 158 AUSTRALIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 159 AUSTRALIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 160 AUSTRALIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 161 AUSTRALIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 162 AUSTRALIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.4.6 SOUTH KOREA
                    9.4.6.1 Growing medical tourism to favor demand for MIS
                                TABLE 163 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 164 SOUTH KOREA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 165 SOUTH KOREA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 166 SOUTH KOREA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 167 SOUTH KOREA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 168 SOUTH KOREA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.4.7 REST OF ASIA PACIFIC
                    TABLE 169 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 170 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 171 REST OF ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 172 REST OF ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 173 REST OF ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 174 REST OF ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 LATIN AMERICA: RECESSION IMPACT
                    TABLE 175 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 176 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 177 LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 178 LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 179 LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 180 LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 181 LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 182 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 183 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.5.2 BRAZIL
                    9.5.2.1 Favorable healthcare policies by government and private organizations to propel market growth
                                TABLE 184 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 185 BRAZIL: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 186 BRAZIL: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 187 BRAZIL: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 188 BRAZIL: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 189 BRAZIL: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.5.3 MEXICO
                    9.5.3.1 Rising adoption of robotics in cosmetic surgeries to drive market
                                TABLE 190 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 191 MEXICO: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 192 MEXICO: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 193 MEXICO: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 194 MEXICO: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 195 MEXICO: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 196 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 197 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 198 REST OF LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 199 REST OF LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 200 REST OF LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 201 REST OF LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 202 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 203 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 204 MIDDLE EAST & AFRICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 205 MIDDLE EAST & AFRICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 206 MIDDLE EAST & AFRICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 207 MIDDLE EAST & AFRICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 208 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 209 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.6.2 GCC COUNTRIES
                    9.6.2.1 Growing demand for minimally invasive procedures
 
10 COMPETITIVE LANDSCAPE (Page No. - 225)
     10.1 OVERVIEW 
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             FIGURE 29 OVERVIEW OF STRATEGIES ADOPTED BY MINIMALLY INVASIVE SURGERY PLAYERS
     10.3 REVENUE SHARE ANALYSIS 
             FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY PLAYERS, 2018–2022 (USD MILLION)
     10.4 MARKET SHARE ANALYSIS 
             10.4.1 GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
                        FIGURE 31 SURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
             10.4.2 GLOBAL IMAGING & VISUALIZATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
                        FIGURE 32 IMAGING & VISUALIZATION SYSTEMS MARKET SHARE ANALYSIS, 2022
             10.4.3 GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
                        FIGURE 33 ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2022
             10.4.4 GLOBAL ELECTROSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
                        FIGURE 34 ELECTROSURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
             10.4.5 GLOBAL MEDICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2022
                        FIGURE 35 MEDICAL ROBOTICS MARKET SHARE ANALYSIS, 2022
                        FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET SHARE, BY PLAYER (2023)
                        TABLE 210 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION
     10.5 COMPANY EVALUATION MATRIX (KEY PLAYERS) 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 37 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
             10.5.5 COMPANY FOOTPRINT
                        FIGURE 38 COMPANY FOOTPRINT (15 COMPANIES)
                        TABLE 211 PRODUCT FOOTPRINT (15 COMPANIES)
                        TABLE 212 REGIONAL FOOTPRINT (15 COMPANIES)
                        TABLE 213 APPLICATION FOOTPRINT (15 COMPANIES)
     10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 39 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
             10.6.5 COMPANY BENCHMARKING
                        TABLE 214 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
                        TABLE 215 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
     10.7 COMPETITIVE SCENARIO 
             10.7.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 216 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021—OCTOBER 2023)
             10.7.2 DEALS
                        TABLE 217 MINIMALLY INVASIVE SURGERY MARKET: DEALS (JANUARY 2021—OCTOBER 2023)
     10.8 COMPANY VALUATION AND FINANCIAL METRICS 
             FIGURE 40 EV/EBITDA OF KEY VENDORS
             FIGURE 41 5-YEAR STOCK BETA OF KEY VENDORS
     10.9 PRODUCT/BRAND COMPARISON 
             FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)
 
11 COMPANY PROFILES (Page No. - 245)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.1.1 MEDTRONIC PLC
                        TABLE 218 MEDTRONIC PLC: COMPANY OVERVIEW
                        FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
                        TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED
                        TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 221 MEDTRONIC PLC: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.2 JOHNSON & JOHNSON MEDTECH
                        TABLE 222 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
                        FIGURE 44 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2022)
                        TABLE 223 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
                        TABLE 224 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 225 JOHNSON & JOHNSON: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.3 STRYKER CORPORATION
                        TABLE 226 STRYKER CORPORATION: COMPANY OVERVIEW
                        FIGURE 45 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 227 STRYKER CORPORATION: PRODUCTS OFFERED
                        TABLE 228 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 229 STRYKER CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.4 BOSTON SCIENTIFIC CORPORATION
                        TABLE 230 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
                        FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 231 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
                        TABLE 232 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 233 BOSTON SCIENTIFIC CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.5 ABBOTT LABORATORIES
                        TABLE 234 ABBOTT LABORATORIES: COMPANY OVERVIEW
                        FIGURE 47 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
                        TABLE 235 ABBOTT LABORATORIES: PRODUCTS OFFERED
                        TABLE 236 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
             11.1.6 ZIMMER BIOMET HOLDINGS, INC.
                        TABLE 237 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
                        FIGURE 48 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2022)
                        TABLE 238 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED
                        TABLE 239 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS (JANUARY 2020–DECEMBER 2023)
             11.1.7 B. BRAUN MELSUNGEN AG
                        TABLE 240 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
                        FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
                        TABLE 241 B. BRAUN MELSUNGEN: PRODUCTS OFFERED
             11.1.8 NUVASIVE, INC.
                        TABLE 242 NUVASIVE, INC: COMPANY OVERVIEW
                        FIGURE 50 NUVASIVE, INC: COMPANY SNAPSHOT (2022)
                        TABLE 243 NUVASIVE INC.: PRODUCTS OFFERED
                        TABLE 244 NUVASIVE, INC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 245 NUVASIVE INC.: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.9 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
                        TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW
                        FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 247 INTEGRA LIFESCIENCES HOLDING CORPORATION: PRODUCTS OFFERED
             11.1.10 ATEC SPINE
                        TABLE 248 ATEC SPINE: COMPANY OVERVIEW
                        FIGURE 52 ATEC SPINE: COMPANY SNAPSHOT (2022)
                        TABLE 249 ATEC SPINE: PRODUCTS OFFERED
             11.1.11 SIEMENS HEALTHINEERS AG
                        TABLE 250 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
                        FIGURE 53 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
                        TABLE 251 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
                        TABLE 252 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 253 SIEMENS HEALTHINEERS AG: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 254 SIEMENS HEALTHINEERS AG: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.1.12 COOK MEDICAL
                        TABLE 255 COOK MEDICAL: COMPANY OVERVIEW
                        TABLE 256 COOK MEDICAL: PRODUCTS OFFERED
             11.1.13 FUJIFILM CORPORATION
                        TABLE 257 FUJIFILM CORPORATION: COMPANY OVERVIEW
                        FIGURE 54 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 258 FUJIFILM CORPORATION: PRODUCTS OFFERED
                        TABLE 259 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 260 FUJIFILM CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 261 FUJIFILM CORPORATION: EXPANSION (JANUARY 2020–DECEMBER 2023)
                        TABLE 262 FUJIFILM CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             11.1.14 BECTON, DICKINSON AND COMPANY
                        TABLE 263 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
                        FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
                        TABLE 264 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
                        TABLE 265 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 266 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             11.1.15 PHILIPS HEALTHCARE
                        TABLE 267 PHILIPS HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 56 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
                        TABLE 268 PHILIPS HEALTHCARE: PRODUCTS OFFERED
                        TABLE 269 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 270 PHILIPS HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.16 GLOBUS MEDICAL, INC.
                        TABLE 271 GLOBUS MEDICAL, INC.: COMPANY OVERVIEW
                        FIGURE 57 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT (2022)
                        TABLE 272 GLOBUS MEDICAL: PRODUCTS OFFERED
                        TABLE 273 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
     11.2 OTHER PLAYERS 
             11.2.1 INTUITIVE SURGICAL INC.
                        TABLE 274 INTUITIVE SURGICAL INC.: COMPANY OVERVIEW
                        FIGURE 58 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2022)
                        TABLE 275 INTUITIVE SURGICAL INC.: PRODUCTS OFFERED
                        TABLE 276 INTUITIVE SURGICAL, INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 277 INTUITIVE SURGICAL, INC.: DEALS (JANUARY 2020–DECEMBER 2023)
             11.2.2 KARL STORZ
                        TABLE 278 KARL STORZ: COMPANY OVERVIEW (2022)
                        TABLE 279 KARL STORZ: PRODUCTS OFFERED
                        TABLE 280 KARL STORZ: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 281 KARL STORZ: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.2.3 EDWARDS LIFESCIENCES CORPORATION
                        TABLE 282 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
                        FIGURE 59 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 283 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
             11.2.4 SMITH+NEPHEW
                        TABLE 284 SMITH+NEPHEW: COMPANY OVERVIEW
                        FIGURE 60 SMITH+NEPHEW: COMPANY SNAPSHOT (2022)
                        TABLE 285 SMITH+NEPHEW: PRODUCTS OFFERED
                        TABLE 286 SMITH+NEPHEW: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 287 SMITH+ NEPHEW: DEALS (JANUARY 2020–DECEMBER 2023)
             11.2.5 GE HEALTHCARE
                        TABLE 288 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 61 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022)
                        TABLE 289 GE HEALTHCARE: PRODUCTS OFFERED
                        TABLE 290 GE HEALTHCARE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 291 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 292 NIPRO CORPORATION: COMPANY OVERVIEW
                        FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 293 NIPRO CORPORATION: PRODUCTS OFFERED
                        TABLE 294 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.2.7 GETINGE AB
                        TABLE 295 GETINGE AB: COMPANY OVERVIEW
                        FIGURE 63 GETINGE AB: COMPANY SNAPSHOT (2022)
                        TABLE 296 GETINGE AB: PRODUCTS OFFERED
             11.2.8 CONMED CORPORATION
                        TABLE 297 CONMED CORPORATION: COMPANY OVERVIEW
                        FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 298 CONMED CORPORATION: PRODUCTS OFFERED
                        TABLE 299 CONMED CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
             11.2.9 TELEFLEX INCORPORATED
                        TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW
                        FIGURE 65 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
                        TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED
                        TABLE 302 TELEFLEX INCORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
             11.2.10 ACCURAY
                        TABLE 303 ACCURAY: COMPANY OVERVIEW
                        FIGURE 66 ACCURAY: COMPANY SNAPSHOT (2022)
                        TABLE 304 ACCURAY: PRODUCTS OFFERED
                        TABLE 305 ACCURAY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 306 ACCURAY: DEALS (JANUARY 2020–DECEMBER 2023)
             11.2.11 OLYMPUS CORPORATION
                        TABLE 307 OLYMPUS CORPORATION: COMPANY OVERVIEW
                        FIGURE 67 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 308 OLYMPUS CORPORATION: PRODUCTS OFFERED
                        TABLE 309 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 310 OLYMPUS CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
             11.2.12 MASIMO
             11.2.13 COOPERSURGICAL INC.
             11.2.14 APPLIED MEDICAL
             11.2.15 RICHARD WOLF
 
12 APPENDIX (Page No. - 351)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the minimally invasive surgery market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in product therapy markets. The primary sources from the demand side include medical OEMs, Analytical instrument OEMs, CDMOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Minimally Invasive Surgery Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the minimally invasive surgery market size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the minimally invasive surgery market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

  • Generating a list of major global players operating in the minimally invasive surgery market.
  • Mapping annual revenues generated by major global players from the minimally invasive surgery market(or nearest reported business unit/product category)
  • Revenue mapping of key  players to cover a major share of the global market, as of 2022
  • Extrapolating the global value of the minimally invasive surgery market

Global Minimally Invasive Surgery Market: Bottom-Up Approach

Minimally Invasive Surgery Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Minimally Invasive Surgery: Top-Down Approach

Minimally Invasive Surgery Market Size, and Share

Minimally Invasive Surgery Market Size, and Share

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the minimally invasive surgery market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the minimally invasive surgery market was  validated using both top-down and bottom-up approaches.

Market Definition

Minimally invasive surgery (MIS) is a surgical procedure done in a manner that causes little to no trauma or injury to a patient. MIS is executed through a cannula using lasers, endoscopes or laparoscopes. MIS involves less bleeding, smaller amounts of anesthesia, less pain, and minimal scarring than other procedures. The surgical instruments used to make minute incisions in the body and perform MIS procedures are minimally invasive.

Key Stakeholders

  • Manufacturers and distributors of minimally invasive surgical instruments
  • Hospitals and clinics
  • Ambulatory surgical centers
  • Research and development (R&D) companies
  • Clinical research organizations
  • Research laboratories and academic institutes
  • Minimally invasive surgical instruments service providers
  • Government associations
  • Venture capitalists and investors

Objectives of the Study

  • To define, describe, and forecast the minimally invasive surgery market on Product, application and end user.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets concerning individual growth trends, prospects,  and contributions to the total market.
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To profile the key market players and comprehensively analyze their market shares and core competencies.
  • To forecast the revenue of the market segments concerning five main regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
  • To track and analyze competitive developments such as new product launches and approvals; agreements, partnerships, expansions, acquisitions; and collaborations in the minimally invasive surgery market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global minimally invasive surgery market

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top thirteen companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to 15)

Geographic Analysis

  • Further breakdown of the Rest of Europe's minimally invasive surgery market Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
  • Further breakdown of the Rest of Asia Pacific minimally invasive surgery market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of the world minimally invasive surgery market Latin America, MEA, and Africa
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1250
Published ON
Mar, 2024
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Minimally Invasive Surgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback